NCT06872853 Evaluation of Rare and Complex Tumours of the Thoraco-Abdominal and Soft Tissue District
| NCT ID | NCT06872853 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna |
| Condition | Rare Malignant Neoplasm |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,100 participants |
| Start Date | 2017-09-29 |
| Primary Completion | 2025-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,100 participants in total. It began in 2017-09-29 with a primary completion date of 2025-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to collect structured data about diagnosis, treatment and follow-up of rare and highly complex neoplasms. The study has a rerospective part that will consist in gathering data on patients accessing IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico di S. Orsola from 01/01/2000 to 28/09/2017 and a prospective one ranging from 29/09/2017 to 31/12/2025.
Eligibility Criteria
Inclusion Criteria: * patients with histologic diagnosis of rare or highly complex malignant neoplasm * informed consent Exclusion Criteria: * none
Contact & Investigator
Maria A Pantaleo, MD
PRINCIPAL INVESTIGATOR
Oncology Unit, IRCCS AOUBO
Frequently Asked Questions
Who can join the NCT06872853 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Rare Malignant Neoplasm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06872853 currently recruiting?
Yes, NCT06872853 is actively recruiting participants. Contact the research team at maria.pantaleo@unibo.it for enrollment information.
Where is the NCT06872853 trial being conducted?
This trial is being conducted at Bologna, Italy, Bologna, Italy.
Who is sponsoring the NCT06872853 clinical trial?
NCT06872853 is sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna. The principal investigator is Maria A Pantaleo, MD at Oncology Unit, IRCCS AOUBO. The trial plans to enroll 1,100 participants.